Manufacture

The industry must overcome enormous challenges in order to take the next steps in induced pluripotent stem cell technology.

How can we reduce animal testing in quality control procedures?

How to drive antibody drug development and manufacture forward safely and quickly.

How is the Indian pharmaceutical industry adapting to meet new demands?

Virus-based vaccines were the first foray into immunization, but the field has had to move on and embrace new approaches.

How do we manage the fallout caused by the COVID-19 pandemic?

Richard Stedman from ACG Engineering outlines the trends driving change in the Indian pharmaceutical equipment industry.

Drug development needs to move more rapidly, but not at the expense of safety.

Is continuous manufacturing worth the investment for pharma companies?

New method to control polymorphism could see “widespread use across the pharma industry”.